000			01888 a2200565 4500
005			20250518074936.0
264		0	_c20210406
008			202104s 0 0 eng d
022			_a1872-8332
024	7		_a10.1016/j.lungcan.2019.11.010 _2doi
040			_aNLM _beng _cNLM
100	1		_aPruis, M A
245	0	0	_aHighly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer. _h[electronic resource]
260			_bLung cancer (Amsterdam, Netherlands) _c02 2020
300			_a46-54 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenocarcinoma of Lung _xdrug therapy
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCrizotinib _xtherapeutic use
650	0	4	_aDNA, Neoplasm _xanalysis
650	0	4	_aDiagnostic Tests, Routine
650	0	4	_aExons
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHigh-Throughput Nucleotide Sequencing
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMutation
650	0	4	_aPrognosis
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aProto-Oncogene Proteins c-met _xantagonists & inhibitors
650	0	4	_aRetrospective Studies
650	0	4	_aSurvival Rate
700	1		_aGeurts-Giele, W R R
700	1		_avon der, Thüsen J H
700	1		_aMeijssen, I C
700	1		_aDinjens, W N M
700	1		_aAerts, J G J V
700	1		_aDingemans, A M C
700	1		_aLolkema, M P
700	1		_aPaats, M S
700	1		_aDubbink, H J
773	0		_tLung cancer (Amsterdam, Netherlands) _gvol. 140 _gp. 46-54
856	4	0	_uhttps://doi.org/10.1016/j.lungcan.2019.11.010 _zAvailable from publisher's website
999			_c30445479 _d30445479